XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.23.1

Net Income Per Share | 9 Months Ended
--- | ---
Mar. 25, 2023
Earnings Per Share [Abstract] |
Net Income Per Share | 3. Net Income Per Share The computation of basic and diluted net income per share was as follows (in millions, except per share data):
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March |  |  | March |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 10.4 |  |  | $ | 64.9 |  |  | $ | 97.0 |  |  | $ | 174.6 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Shares, basic |  |  | 39.4 |  |  |  | 39.5 |  |  |  | 39.7 |  |  |  | 38.8 |
Effect of dilutive share-based awards and convertible notes |  |  | 0.5 |  |  |  | 1.2 |  |  |  | 0.6 |  |  |  | 1.9 |
Shares, diluted |  |  | 39.9 |  |  |  | 40.7 |  |  |  | 40.3 |  |  |  | 40.7 |
Net income per share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.26 |  |  | $ | 1.64 |  |  | $ | 2.44 |  |  | $ | 4.50 |
Diluted |  | $ | 0.26 |  |  | $ | 1.59 |  |  | $ | 2.41 |  |  | $ | 4.29 |
Our basic net income per share amounts for each period presented have been computed using the weighted average number of shares of common stock, $0.001 par value, or the common stock, outstanding over the period measured. Our diluted net income per share amounts for each period presented include the weighted average effect of potentially dilutive shares. We use the "treasury stock" method to determine the dilutive effect of our stock options, restricted stock units, or RSUs, market stock units, or MSUs, performance stock units, or PSUs, and our convertible notes, which were settled in August 2021. Dilutive net income per share amounts do not include the potential weighted average effect of 920,655 and 68,521 shares of common stock related to certain share-based awards that were outstanding during the three months ended March 2023 and March 2022, respectively, and 665,898 and 31,430 shares of common stock related to certain share-based awards that were outstanding during nine months ended March 2023 and March 2022, respectively. These share-based awards were not included in the computation of diluted net income per share because their effect would have been antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration